Home LiteratureArticle Details
PMID: 7983975 Published · ppublish English Clinical Trial Clinical Trial, Phase I Letter

Tumour stimulating effects of recombinant human interleukin-6.

Lancet (London, England) ·Vol. 344 ·No. 8936 ·1994-12-03 ·Pages 1576-7

Ravoet C, DeGrève J, Vandewoude K, Kerger J, Sculier JP, Lacor P, Stryckmans P, Piccart M

Abstract

暂无摘要

MeSH Terms
Adult Carcinoma, Renal Cell/pathology,therapy Female Humans Interleukin-6/adverse effects Kidney Neoplasms/pathology,therapy Liver Neoplasms/secondary,therapy Lung Neoplasms/secondary Male Middle Aged Retrospective Studies
Chemicals
Interleukin-6
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Ravoet C
DeGrève J
Vandewoude K
Kerger J
Sculier J P
Lacor P
Stryckmans P
Piccart M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(94)90387-5
Published
1994-12-03
Pages
1576-7
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(94)90387-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2